While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Jared Holz, Mizuho Healthcare Sector strategist, joins 'Closing Bell Overtime' to talk Moderna and Novo Nordisk.

Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron subvariants BA.4 and BA.5. The US regulator has cleared a 30 µg booster dose of a new ...

The two companies have submitted data from a phase 1 trial in support of the booster dose to the ... of either the Pfizer/BioNTech or Moderna COVID-19 vaccines for people with "moderately to ...

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

Delawareans can enjoy a regional staple and snag a free t-shirt Friday as a new Wawa hosts a grand opening on Naamans Road in ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

The Department of Health Services has awarded $590 million to Moderna to speed up the development of flu vaccines, including ...